JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

A8501 PHA-848125

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor,potent and ATP-competitive

≥23.05 mg/mL
A8641 LEE011

Target: Cyclin-Dependent Kinases

Summary: CDK4/6 inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
B4736 THZ1 Hydrochloride

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥30.13 mg/mL
B3277 AMG 925

Target: Cyclin-Dependent Kinases|FLT3

Summary: FLT3/CDK4 inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A8717 THZ2

1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥28.3 mg/mL
A8882 THZ1

12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL
A1980 SNS-032 (BMS-387032)

2 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor

insoluble in H2O; ≥19.05 mg/mL
A5459 PHA-793887

1 Citation

Target: Cyclin-Dependent Kinases

Summary: Pan-Cdk inhibitor

insoluble in H2O; ≥18.05 mg/mL
A3721 PHA-767491

Target: Cyclin-Dependent Kinases|MK2|Cdc7

Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive

insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
A8565 Purvalanol B

1 Citation

Target: Cyclin-Dependent Kinases

Summary: CDK1/CDK2/CDK4 inhibitor

≥21.65 mg/mL